METABOLISM, PHARMACOKINETICS, TISSUE DISTRIBUTION, AND EXCRETION OF [14C]CP-424391 IN RATS

@article{KhojastehBakht2005METABOLISMPT,
  title={METABOLISM, PHARMACOKINETICS, TISSUE DISTRIBUTION, AND EXCRETION OF [14C]CP-424391 IN RATS},
  author={Siamak Cyrus Khojasteh-Bakht and John P O'Donnell and Hassan G. Fouda and Michael J. Potchoiba},
  journal={Drug Metabolism and Disposition},
  year={2005},
  volume={33},
  pages={190 - 199}
}
CP-424391, 2-amino-N-[3aR-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo[4,3-c]pyridin-5-yl)-1R-benzyloxymethyl-2-oxoethyl]-isobutyramide, is an orally active growth hormone secretagogue currently being developed. In this study, we investigated the metabolic fate and disposition of radiolabeled CP-424391 in rats. Following 15 mg/kg single oral administration to Sprague-Dawley rats, 91% of the radiolabeled dose was recovered. Feces was the major route of excretion: 77% of the dose… 
View on ASPET
web.archive.org
8 Citations

8 Citations

Recent progress toward nonpeptide ligands for the melanocortin-4 receptor.
  • Chen Chen
  • Biology, Chemistry
    Progress in medicinal chemistry
  • 2007
Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate.
TLDR
The identification of potent, highly selective orally bioavailable ghrelin receptor inverse agonists from a spiro-azetidino-piperidine series has promising in vivo pharmacokinetics and increase glucose-stimulated insulin secretion in human whole and dispersed islets.
Peripheral elevation of IGF-1 fails to alter Abeta clearance in multiple in vivo models.
Aortic Binding of AZD5248: Mechanistic Insight and Reactivity Assays To Support Lead Optimzation.
TLDR
Results obtained with AZD5248, literature compounds, and close analogues of AZD 5248 support the mechanistic hypothesis and provide validation for the use of these assays in a two tier screening approach to support lead optimization.
Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptor.
From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation
TLDR
Improving the ability of ghrelin ligands to penetrate the blood brain barrier would enhance central delivery to GHSR-1a expressing brain regions, particularly within the mesolimbic reward circuitry.
Small molecule ghrelin receptor inverse agonists and antagonists.
TLDR
This review provides an overview of ghrelin biology with a focus on metabolic diseases and summarizes recent medicinal chemistry programs aimed at delivering small molecule ghrelIn receptor antagonists and inverse agonists to the clinic.
The aging population--is there a role for endocrine interventions?

References

SHOWING 1-10 OF 26 REFERENCES
Preclinical pharmacology of CP-424,391, and orally active pyrazolinone-piperidine growth hormone secretagogue
TLDR
The peptidomimetic GHS 391 has potential utility for the treatment of clinical conditions that could benefit from systemic augmentation of GH and IGF-1 levels and chronic oral administration of 391 augmented body weight gain in rats and dogs.
Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.
TLDR
Deconvolution analysis demonstrated that the increase in serum GH concentrations stimulated by L and GHRH resulted from enhanced GH secretion rates, with no change in the half-life of GH disappearance.
Studies on the mechanism of drug-binding to melanin.
The concentration of phenothiazines in the eye of experimental animals.
TLDR
Derivatives of IS!-substituted phenothiazine are concentrated in the tissues of the uveal tract of pigmented animals and species and compound differences in the concentration phenomenon are noted.
Quantitative comparison of autoradioluminographic and radiometric tissue distribution studies using carbon-14 labeled xenobiotics.
TLDR
Results indicated that the quantitation of tissue radioactivity by WBAL was as precise as DLSA evaluation, and WBAL also provided results to the quantitative distribution of radioactivity to localized sites in organs not feasible by DLSA.
Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulin-like growth factor-I axis in selected GH-deficient adults.
TLDR
Oral administration of such GHRP-mimetic compounds may have a role in the treatment of GH deficiency of childhood onset, and the clinical significance of these changes will need to be assessed in longer term studies.
A novel quantitative method for determining the biodistribution of radiolabeled xenobiotics using whole-body cryosectioning and autoradioluminography.
TLDR
It is demonstrated that autoradioluminography provided a sensitive, accurate, precise and reproducible method for the quantitative measurement of the tissue distribution of [14C]-radiolabeled xenobiotics in whole-body cryosections.
The Effects of Growth Hormone on Glucose & Protein Metabolism
TLDR
Following the full characterisation and identification of growth hormone (GH) a number of studies were performed that demonstrated profound effects on glucose metabolism and mechanisms are poorly understood.
Interaction between chemicals and melanin.
TLDR
Various drugs and other chemicals, such as organic amines, metals, polycyclic aromatic hydrocarbons, etc., are bound to melanin and retained in pigmented tissues for long periods and there are many indications of a connection between the melanin affinity of these agents and the induction of malignant melanoma.
The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients.
TLDR
GH treatment for 10 yr in GHD adults resulted in increased lean body and muscle mass, a less atherogenic lipid profile, reduced carotid intima media thickness, and improved psychological well-being.
...
...